Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Carl Zeiss Meditec AG
  6. Summary
    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 06/18 04:00:00 pm
157.525 EUR   +0.82%
05/28CARL ZEISS MEDITEC AG : Ex-dividend day for final dividend
FA
05/26CARL ZEISS MEDITEC AG  : NorldLB reiterates its Buy rating
MD
05/26CARL ZEISS MEDITEC AG  : Berenberg sticks Neutral
MD
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
06/14/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
154.15(c) 154.2(c) 154.9(c) 156.25(c) 157.85 Last
70 676 65 027 74 781 87 483 317 407 Volume
+0.55% +0.03% +0.45% +0.87% +1.02% Change
More quotes
Financials
Sales 2021 1 601 M 1 901 M 1 901 M
Net income 2021 203 M 241 M 241 M
Net cash position 2021 701 M 832 M 832 M
P/E ratio 2021 67,7x
Yield 2021 0,47%
Sales 2022 1 721 M 2 043 M 2 043 M
Net income 2022 227 M 269 M 269 M
Net cash position 2022 698 M 829 M 829 M
P/E ratio 2022 61,8x
Yield 2022 0,55%
Capitalization 14 118 M 16 738 M 16 764 M
EV / Sales 2021 8,38x
EV / Sales 2022 7,80x
Nbr of Employees 3 371
Free-Float 40,9%
More Financials
Company
Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology,... 
More about the company
Ratings of Carl Zeiss Meditec AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about CARL ZEISS MEDITEC AG
05/28CARL ZEISS MEDITEC AG : Ex-dividend day for final dividend
FA
05/26CARL ZEISS MEDITEC AG  : NorldLB reiterates its Buy rating
MD
05/26CARL ZEISS MEDITEC AG  : Berenberg sticks Neutral
MD
05/17CARL ZEISS MEDITEC AG  : DZ Bank remains Neutral
MD
05/11CARL ZEISS MEDITEC AG  : Deutsche Bank gives a Buy rating
MD
05/10GLOBAL MARKETS LIVE : Coty, Marriott, Tyson Foods, Traton, Ford...
05/10CARL ZEISS MEDITEC  : returns to significant revenue growth in H1 2020/21
AQ
05/10PRESS RELEASE : Carl Zeiss Meditec returns to significant revenue growth in H1 2..
DJ
05/10CARL ZEISS MEDITEC  : returns to significant revenue growth in H1 2020/21
EQ
05/06CARL ZEISS MEDITEC  : Half Year Report 2020/21
PU
05/03DGAP-AFR  : Carl Zeiss Meditec AG: Preliminary announcement of the publication o..
DJ
04/20CARL ZEISS MEDITEC AG  : Kepler Cheuvreux remains Neutral
MD
04/20CARL ZEISS MEDITEC AG  : Sell rating from Independant Research
MD
04/20CARL ZEISS MEDITEC AG  : Deutsche Bank gives a Buy rating
MD
04/19CARL ZEISS MEDITEC AG  : returns to significant revenue growth in second quarter..
AQ
More news
News in other languages on CARL ZEISS MEDITEC AG
06/10PTA-NEWS : Serviceware SE: Führendes österreichisches Gesundheitsunternehmen set..
05/27Neuer Aufsichtsratschef bei der Carl Zeiss Meditec AG
05/27Tagesvorschau International
05/27TAGESVORSCHAU : Termine am 27. Mai 2021
05/26Aktionärstreffen der Carl Zeiss Meditec AG
More news
Analyst Recommendations on CARL ZEISS MEDITEC AG
More recommendations
Stock Trading Strategies
CARL ZEISS MEDITEC AG - 04/08
Good timing to anticipate a continuation of the trend
BUY
More Stock Trading Analysis
Chart CARL ZEISS MEDITEC AG
Duration : Period :
Carl Zeiss Meditec AG Technical Analysis Chart | AFX | DE0005313704 | MarketScreener
Technical analysis trends CARL ZEISS MEDITEC AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 135,27 €
Last Close Price 156,25 €
Spread / Highest target 12,6%
Spread / Average Target -13,4%
Spread / Lowest Target -59,0%
EPS Revisions
Managers and Directors
NameTitle
Ludwin Monz President & Chief Executive Officer
Justus Felix Wehmer Chief Financial Officer
Michael Kaschke Chairman-Supervisory Board
Markus Guthoff Member-Supervisory Board
Christian Müller Member-Supervisory Board
Sector and Competitors